Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2.
The COVID pandemic fueled by emerging SARS-CoV-2 new variants of concern remains a major global health concern, and the constantly emerging mutations present challenges to current therapeutics. The spike glycoprotein is not only essential for the initial viral entry, but is also responsible for the...
Saved in:
| Main Authors: | Shi Yu, Xu Zheng, Yanqiu Zhou, Yuhui Gao, Bingjie Zhou, Yapei Zhao, Tingting Li, Yunyi Li, Jiabin Mou, Xiaoxian Cui, Yuying Yang, Dianfan Li, Min Chen, Dimitri Lavillette, Guangxun Meng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-11-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1011789 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody
by: Tingting Li, et al.
Published: (2021-11-01) -
Correction: Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2
Published: (2025-08-01) -
Correction: Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2.
by: PLOS Pathogens Staff
Published: (2025-08-01) -
SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01) -
Display of Native SARS-CoV-2 Spike on Mammalian Cells to Measure Antibody Affinity and ADCC
by: Rebecca Wilen, et al.
Published: (2024-11-01)